Internal Medicine Doctors in Coeburn, VA Accepting Medicare
3 Internal Medicine doctors found. Showing 1 - 3
 Dr. Gucharan S Kanwal, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 116 Centre Ave Ne, Coeburn, VA 24230 Phone: 276-395-6244 Fax: 276-395-3058 |
Joseph F Smiddy, M.D. Internal Medicine - Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 208 Front St W, Coeburn, VA 24230 Phone: 276-455-5556 Fax: 276-455-5557 |
Thomas E Renfro, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 515 Front St W, Coeburn, VA 24230 Phone: 276-395-2389 Fax: 276-395-6634 |
News Archive
Robotic-assisted radical prostatectomy shows better outcomes in cancer removal
An observational study from UCLA's Jonsson Comprehensive Cancer comparing robotic-assisted prostate surgery to open surgery for prostate cancer found that patients who had robotic surgery had fewer instances of cancer cells at the edge of the surgical specimen, or fewer positive margins, and less need of additional cancer treatments, such as hormone therapy or radiation, than patients who had open surgery.
Polygenic risk scores based on entire genome sequence may reliably predict heart disease
Specialized risk scores derived from testing that calculates the cumulative effect of an individual's entire DNA sequence, the genome, may reliably predict heart disease in people who have not yet had a heart attack, according to new research in Circulation: Genomic and Precision Medicine, an American Heart Association journal.
President Obama announces $155M in humanitarian aid to Syria
"President Barack Obama on Tuesday approved an additional $155 million of humanitarian aid and announced it himself in order to underscore to the Syrian people and the international community the U.S. commitment to assisting Syrians and other refugees in need of immediate, lifesaving assistance as a result of Syrian President Bashar al-Assad's brutality," the State Department's "DipNote" blog reports.
Targeted therapy achieves durable objective responses Phase I/II LIBRETTO-001 trial
For patients with non-small cell lung cancers (NSCLC) marked by RET gene fusions, the targeted therapy selpercatinib was well tolerated and achieved durable objective responses, or tumor shrinkage, in the majority of participants in the Phase I/II LIBRETTO-001 trial, according to researchers from The University of Texas MD Anderson Cancer Center.
Scientists have, for the first time, induced a state of reversible metabolic hibernation in mice
Scientists at Fred Hutchinson Cancer Research Center have, for the first time, induced a state of reversible metabolic hibernation in mice. This achievement, the first demonstration of "hibernation on demand" in a mammal, ultimately could lead to new ways to treat cancer and prevent injury and death from insufficient blood supply to organs and tissues.
› Verified 4 days ago